Vivo Capital, LLC Aclaris Therapeutics, Inc. Transaction History

Vivo Capital, LLC

  • $472 Million
  • Q2 2025

A detailed history of Vivo Capital, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 8,888,888 shares of ACRS stock, worth $14.6 Million. This represents 2.67% of its overall portfolio holdings.

Number of Shares
8,888,888
Previous 8,888,888 -0.0%
Holding current value
$14.6 Million
Previous $13.6 Million 7.18%
% of portfolio
2.67%
Previous 3.69%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$1.15 - $4.59 $10.2 Million - $40.8 Million
8,888,888 New
8,888,888 $22 Million
Q1 2022

May 13, 2022
SELL
$9.74 - $17.92 $217,698 - $400,529
-22,351 Reduced 2.43%
898,631 $15.5 Million
Q4 2021

Feb 11, 2022
SELL
$12.27 - $18.49 $242,602 - $365,584
-19,772 Reduced 2.1%
920,982 $13.4 Million
Q3 2021

Nov 15, 2021
SELL
$13.38 - $18.8 $5.8 Million - $8.15 Million
-433,525 Reduced 31.55%
940,754 $16.9 Million
Q2 2021

Aug 16, 2021
SELL
$17.08 - $29.6 $4.66 Million - $8.08 Million
-272,935 Reduced 16.57%
1,374,279 $24.1 Million
Q1 2020

May 15, 2020
BUY
$0.75 - $2.18 $1.24 Million - $3.59 Million
1,647,214 New
1,647,214 $1.71 Million
Q3 2019

Nov 13, 2019
SELL
$0.79 - $2.47 $1.3 Million - $4.07 Million
-1,647,214 Closed
0 $0
Q4 2017

Feb 09, 2018
SELL
$21.47 - $27.8 $26 Million - $33.7 Million
-1,211,355 Reduced 42.38%
1,647,214 $40.6 Million
Q3 2017

Nov 13, 2017
BUY
$23.02 - $28.8 $65.8 Million - $82.3 Million
2,858,569
2,858,569 $73.8 Million

Others Institutions Holding ACRS

# of Institutions
98
Shares Held
87.7M
Call Options Held
0
Put Options Held
0
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $109M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email